Zota Health Care

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358U01012
  • NSEID: ZOTA
  • BSEID:
INR
1,307.60
33.2 (2.61%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 166132

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
538.66
292.97
180.49
139.96
131.19
106.79
95.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
538.66
292.97
180.49
139.96
131.19
106.79
95.11
Raw Material Cost
17.46
16.23
12.77
17.41
19.97
20.19
13.04
Purchase of Finished goods
285.35
162.58
95.20
81.84
66.08
55.29
46.17
(Increase) / Decrease In Stocks
-88.84
-41.50
-11.28
-15.98
0.56
-2.19
7.09
Employee Cost
178.33
86.07
30.45
12.91
10.24
9.30
10.34
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
127.82
75.33
45.78
36.44
19.54
23.57
13.95
Total Expenditure (Excl Depreciation)
520.12
298.70
172.93
132.62
116.40
106.16
90.59
Operating Profit (PBDIT) excl Other Income
18.54
-5.73
7.56
7.34
14.79
0.63
4.52
Other Income
7.44
2.07
1.16
1.96
1.63
1.26
1.51
Operating Profit (PBDIT)
25.98
-3.66
8.72
9.30
16.42
1.89
6.03
Interest
17.36
10.78
4.79
2.56
0.32
0.11
0.07
Exceptional Items
-6.00
0.00
0.00
0.54
0.00
1.03
0.00
Gross Profit (PBDT)
2.62
-14.44
3.93
7.28
16.10
2.81
5.96
Depreciation
82.45
43.20
20.09
11.96
3.67
3.17
2.10
Profit Before Tax
-79.84
-57.64
-16.16
-4.69
12.44
-0.37
3.86
Tax
-5.76
-0.91
-1.82
1.08
3.53
-0.16
1.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-74.08
-56.74
-14.35
-5.77
8.91
-0.21
2.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-74.08
-56.74
-14.35
-5.77
8.91
-0.21
2.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.14
0.34
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-73.94
-56.40
-14.35
-5.77
8.91
-0.21
2.74
Equity Capital
34.63
28.64
25.85
25.16
25.16
24.56
24.56
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
644.82
195.05
64.13
55.20
64.47
41.74
44.27
Earnings per share (EPS)
-21.35
-19.69
-5.55
-2.29
3.54
-0.09
1.12
Diluted Earnings per share
-22.46
-19.06
-5.47
-2.29
3.58
-0.09
1.12
Operating Profit Margin (Excl OI)
3.44%
-1.96%
4.19%
5.24%
11.27%
0.59%
4.75%
Gross Profit Margin
0.49%
-4.93%
2.18%
5.2%
12.27%
2.63%
6.27%
PAT Margin
-13.75%
-19.37%
-7.95%
-4.12%
6.79%
-0.2%
2.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 83.86% vs 62.32% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -31.10% vs -293.03% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 423.56% vs -175.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 61.04% vs 125.05% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Zota Health Care With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
538.66
927.11
-388.45
-41.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
538.66
927.11
-388.45
-41.90%
Raw Material Cost
17.46
386.26
-368.80
-95.48%
Purchase of Finished goods
285.35
61.25
224.10
365.88%
(Increase) / Decrease In Stocks
-88.84
-22.44
-66.40
-295.90%
Employee Cost
178.33
136.43
41.90
30.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
127.82
201.59
-73.77
-36.59%
Total Expenditure (Excl Depreciation)
520.12
763.08
-242.96
-31.84%
Operating Profit (PBDIT) excl Other Income
18.54
164.03
-145.49
-88.70%
Other Income
7.44
73.53
-66.09
-89.88%
Operating Profit (PBDIT)
25.98
237.56
-211.58
-89.06%
Interest
17.36
12.01
5.35
44.55%
Exceptional Items
-6.00
-2.49
-3.51
-140.96%
Gross Profit (PBDT)
2.62
223.06
-220.44
-98.83%
Depreciation
82.45
33.48
48.97
146.27%
Profit Before Tax
-79.84
189.59
-269.43
-142.11%
Tax
-5.76
54.86
-60.62
-110.50%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-74.08
134.73
-208.81
-154.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-74.08
134.73
-208.81
-154.98%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.14
-5.60
5.74
102.50%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-73.94
129.13
-203.07
-157.26%
Equity Capital
34.63
10.58
24.05
227.32%
Face Value
10.00
1.00
0.00
Reserves
644.82
1,182.32
-537.50
-45.46%
Earnings per share (EPS)
-21.35
12.21
-33.56
-274.86%
Diluted Earnings per share
-22.46
12.00
-34.46
-287.17%
Operating Profit Margin (Excl OI)
3.44%
17.69%
0.00
-14.25%
Gross Profit Margin
0.49%
24.06%
0.00
-23.57%
PAT Margin
-13.75%
14.53%
0.00
-28.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 538.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 83.86% vs 62.32% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit -73.94 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -31.10% vs -293.03% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 423.56% vs -175.79% in Mar 2025

Annual - Interest
Interest 17.36 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 61.04% vs 125.05% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.44%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025